Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of quadrivalent split-virion influenza vaccine in people aged 3 years and older
CTR20202605Phase 3Active
- Sponsor
- Liaoning Chengda Biotechnology Co., Ltd.
- Start
- Mar 2021
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of influenza vaccine in influenza, sponsored by Liaoning Chengda Biotechnology Co., Ltd.. Started Mar 2021; status: active.
02
Drugs
influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on CTR20202605.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20202605.